GeneDx Holdings Total Current Assets 2020-2025 | WGS
GeneDx Holdings total current assets from 2020 to 2025. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
| GeneDx Holdings Annual Total Current Assets (Millions of US $) |
|
|---|---|
| 2024 | $198 |
| 2023 | $182 |
| 2022 | $213 |
| 2021 | $484 |
| 2020 | $174 |
| 2019 | $0 |
| GeneDx Holdings Quarterly Total Current Assets (Millions of US $) |
|
|---|---|
| 2025-03-31 | $226 |
| 2024-12-31 | $198 |
| 2024-09-30 | $186 |
| 2024-06-30 | $162 |
| 2024-03-31 | $163 |
| 2023-12-31 | $182 |
| 2023-09-30 | $172 |
| 2023-06-30 | $213 |
| 2023-03-31 | $272 |
| 2022-12-31 | $213 |
| 2022-09-30 | $307 |
| 2022-06-30 | $403 |
| 2022-03-31 | $410 |
| 2021-12-31 | $484 |
| 2021-09-30 | $539 |
| 2021-06-30 | $0 |
| 2021-03-31 | $1 |
| 2020-12-31 | |
| 2020-09-30 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.295B | $0.305B |
| GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $139.405B | 26.15 |
| CVS Health (CVS) | United States | $80.076B | 9.95 |
| Elevance Health (ELV) | United States | $68.334B | 9.16 |
| Cencora (COR) | United States | $57.058B | 19.85 |
| DiDi Global (DIDIY) | China | $27.204B | 28.90 |
| Labcorp Holdings (LH) | United States | $20.694B | 16.78 |
| Natera (NTRA) | United States | $19.578B | 0.00 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.895B | 0.00 |
| CochLear (CHEOY) | Australia | $13.107B | 0.00 |
| Solventum (SOLV) | United States | $12.779B | 13.53 |
| ICON (ICLR) | Ireland | $11.862B | 11.03 |
| Revvity (RVTY) | United States | $11.266B | 19.39 |
| Viatris (VTRS) | United States | $10.880B | 3.74 |
| Medpace Holdings (MEDP) | United States | $9.173B | 24.36 |
| Avantor (AVTR) | United States | $9.056B | 13.16 |
| Sonic Healthcare (SKHHY) | Australia | $8.822B | 0.00 |
| HealthEquity (HQY) | United States | $8.658B | 37.92 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.959B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.696B | 15.08 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $5.017B | 29.54 |
| BrightSpring Health Services (BTSG) | United States | $3.534B | 32.42 |
| Sotera Health (SHC) | United States | $3.188B | 18.11 |
| Surgery Partners (SGRY) | United States | $2.899B | 37.70 |
| Alignment Healthcare (ALHC) | United States | $2.602B | 0.00 |
| Concentras Parent (CON) | United States | $2.533B | 14.64 |
| Organon (OGN) | United States | $2.506B | 2.66 |
| Progyny (PGNY) | United States | $1.972B | 43.42 |
| PACS (PACS) | United States | $1.876B | 0.00 |
| Premier (PINC) | United States | $1.735B | 13.17 |
| GoodRx Holdings (GDRX) | United States | $1.689B | 33.79 |
| Ardent Health (ARDT) | United States | $1.656B | 7.06 |
| Teladoc Health (TDOC) | United States | $1.410B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $1.277B | 438.00 |
| Establishment Labs Holdings (ESTA) | $1.228B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.103B | 8.39 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.898B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.779B | 7.29 |
| CareDx (CDNA) | United States | $0.658B | 10.27 |
| Nutex Health (NUTX) | United States | $0.615B | 9.32 |
| Embecta (EMBC) | United States | $0.576B | 3.88 |
| InnovAge Holding (INNV) | United States | $0.571B | 0.00 |
| SBC Medicals (SBC) | United States | $0.569B | 0.00 |
| So-Young (SY) | China | $0.507B | 0.00 |
| LifeMD (LFMD) | United States | $0.504B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.476B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.474B | 10.68 |
| Omada Health (OMDA) | $0.456B | 0.00 | |
| COMPASS Pathways (CMPS) | United Kingdom | $0.363B | 0.00 |
| Enhabit (EHAB) | United States | $0.337B | 27.75 |
| Oncology Institute (TOI) | United States | $0.326B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.315B | 0.00 |
| Beauty Health (SKIN) | United States | $0.209B | 0.00 |
| DocGo (DCGO) | United States | $0.148B | 24.17 |
| Pheton Holdings (PTHL) | China | $0.143B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.113B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.078B | 0.00 |
| KindlyMD (NAKA) | United States | $0.069B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.052B | 0.00 |
| Biodesix (BDSX) | United States | $0.046B | 0.00 |
| ModivCare (MODV) | United States | $0.044B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.012B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |